Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? A single-center phase 2 study

Oncology

Volumn 64, Issue 4, 2003, Pages 479-480

  Rossi, Emanuela ^a   Perrone, Francesco ^a   Labonia, Vincenzo ^a   Landi, Gabriella ^a   Nuzzo, Francesco ^a   Amabile, Gerardo ^a   Gridelli, Cesare ^b   Di Maio, Massimo ^a   D'Aiuto, Giuseppe ^a   De Matteis, Andrea ^a,c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Civil Hospital   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ESTROGEN RECEPTOR; GEMCITABINE; NAVELBINE; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; VINBLASTINE;

ADULT; AGED; ANEMIA; ANOREXIA; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; COLITIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEBRILE NEUTROPENIA; FEVER; HAIR LOSS; HEADACHE; HUMAN; LETTER; LEUKOPENIA; LIVER TOXICITY; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; SKIN TOXICITY; THROMBOCYTOPENIA; TOXICITY; VOMITING; WEIGHT REDUCTION; BREAST TUMOR; DRUG ADMINISTRATION; FEMALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SALVAGE THERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; SALVAGE THERAPY; TREATMENT OUTCOME; VINBLASTINE;

EID: 0037974853     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070313     Document Type: Letter

References (6)

1. Gasparini G, Caffo O, Barni S, Frontini L, Testolin A, Guglielmi RB, Ambrosini G: Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: A phase II study. J Clin Oncol 1994;12:2094-2101.
2. Carmichael J, Possinger K, Phillip P, Beykirch M, Kerr H, Walling J, Harris AL: Advanced breast cancer: A phase II trial with gemcitabine. J Clin Oncol 1995;13:2731-2736.
3. Haider K, Kornek GV, Kwasny W, Weinlander G, Valencak J, Lang F, Puribauer F, Kovats E, Depisch D, Scheithauer W: Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor. Breast Cancer Res Treat 1999;55:203-211.
4. Gridelli C, Frontini L, Perrone F, Gallo C, Gulisano M, Cigolari S, Castiglione F, Robbiati SF, Gasparini G, Ianniello GP, Farris A, Locatelli MC, Felletti R, Piazza E on behalf of the GemVin Investigators: Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: A phase II study of three different doses. Br J Cancer 2000;83:707-714.
5. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-216.
6. Budman DR, Calabro A, Kreis W: In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agents. Anticancer Drugs 1998;9:697-702.